Logo Pure Precision
U
Newsletter
Contact us
  • Precision Capturing®
    • Precision Capturing® Technology
    • Recombinant Protein Purification
    • Antibody Purification
    • Precision Capturing Pipeline
  • Precision Targeting
    • Precision Targeting Technology
    • Protein Drug Conjugates
    • Radio Conjugates
    • Cellular Therapy
    • Multispecific Ligands
    • Precision Targeting Pipeline
  • Company
    • Who we are
    • Team
  • Resources
    • Capturing – Blog
    • Capturing – Whitepapers
    • Capturing – Publications
    • Targeting – Publications
  • News
    • Press
    • Events
  • Career
    • Career
    • Open Positions
  • Contact
NAVIGO Logo1
  • Precision Capturing®
    • Precision Capturing® Technology
    • Recombinant Protein Purification
    • Antibody Purification
    • Precision Capturing Pipeline
  • Precision Targeting
    • Precision Targeting Technology
    • Protein Drug Conjugates
    • Radio Conjugates
    • Cellular Therapy
    • Multispecific Ligands
    • Precision Targeting Pipeline
  • Company
    • Who we are
    • Team
  • Resources
    • Capturing – Blog
    • Capturing – Whitepapers
    • Capturing – Publications
    • Targeting – Publications
  • News
    • Press
    • Events
  • Career
    • Career
    • Open Positions
  • Contact

Navigo Proteins and MDimune Enter into a Research Collaboration on Affilin®-Mediated Targeting of Extracellular Vesicles

by NAVIGO USER_1 | May 11, 2021 | Press

Solid tumor-specific scaffold protein ligands from Navigo combined with MDimune’s BioDrone® technology to create novel targeted extracellular vesicle-based therapeutics Halle/Saale, Germany and Seoul, Korea, May 11th, 2021. Navigo Proteins, a protein engineering...

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Purification of Human Complement-Factor H

by NAVIGO USER_1 | Mar 16, 2021 | Press

Custom Affinity Chromatography Resin Promises High Yield Purification in Clinical and Commercial GMP Downstream Processing Halle/Saale, Germany and Freiburg, Germany, March 16th, 2021. Navigo Proteins GmbH (“Navigo”), a premier protein engineering company, developer...
Next Entries »

Recent Posts

  • Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19
  • Navigo Proteins Successfully Develops Affinity Resin against Ferritin for blood fraction processing
  • Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64
  • Navigo Proteins Appoints Chris-Carol Bremer as Chief Development Officer
  • ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

Recent Comments

    Navigo Proteins GmbH
    Heinrich-Damerow-Straße 1
    06120 Halle (Saale)
    Germany

    Phone: +49 345 27996-330
    Fax: +49 345 27996-332
    E-Mail: info@navigo-proteins.com

    Precision Capturing®
    Precision Targeting
    Company
    News
    Career
    Contact
    Imprint
    Disclaimer
    Data Protection

    Social Media

    • Follow

    © Navigo Proteins GmbH

    ×
    Generic selectors
    Exact matches only
    Search in title
    Search in content
    Post Type Selectors